Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Humanised Fc-engineered monoclonal antibody against CD19

EU orphan designation number: EU/3/17/1962   
Active ingredient: Humanised Fc-engineered monoclonal antibody against CD19
Indication: Treatment of IgG4-related disease
Sponsor: MWB Consulting S.A.R.L.
1 La Cour, 50210 Belval, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/01/2018 Orphan designation EMA/OD/155/17 (2018)383 of 17/01/2018
21/11/2018 Transfer of orphan designation EMA/OD/155/17/T/01 (2018)7815 of 19/11/2018